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Cefdinir Prescribing Increased in Low-Income Children in Kentucky From
Background. Cefdinir is frequently prescribed to pediatric outpatients with respiratory infections despite a lack of first-line indications. The use of cefdinir should be limited given its poor efficacy against Streptococcus pneumoniae, suboptimal pharmacokinetic and pharmacodynamic parameters, and high cost. We describe cefdinir use over time in the pediatric Kentucky (KY) Medicaid population including rates of use, associated diagnoses, and cost to the Medicaid system. Methods. We reviewed KY Medicaid pharmacy and medical claims from 2012 to 2016 for all patients <20 years of age. Cefdinir prescriptions were identified by national drug codes and linked to medical claims within 3 days prior to the prescription date. Diagnoses were classified into the following groups by ICD9 and ICD10 codes: acute otitis media (AOM), sinusitis, pharyngitis, lower respiratory infections, and urinary tract infections. Upper respiratory infections (URIs) commonly caused by viruses (e.g., nasopharyngitis, bronchitis, cough) were categorized as presumed viral infections. Cost data were extracted from pharmacy claims. Cochran-Armitage was used to test for trends across the study period.
Results. Cefdinir prescriptions significantly increased from 60,334 (8% of all antibiotic prescriptions) in 2012 to 99,053 (13% of all antibiotic prescriptions) in 2016 (P < 0.001). Cefdinir use in rate per 1,000 children increased from 195 in 2012 to 294 in 2016. Medicaid spending on cefdinir increased from $2.3M (15% of all antibiotic spending) in 2012 to $4.7M (27% of all spending) in 2016. Eighty-eight percent of pharmacy claims for cefdinir had an associated medical claim within 3 days prior to prescription. Indications associated with cefdinir are summarized in Figure 1 . Three groups accounted for the majority of cefdinir use: AOM, presumed viral infections, and pharyngitis.
Conclusion. Outpatient cefdinir use in pediatric patients served by KY Medicaid significantly increased over the study period. Much of this use was inappropriate. Antibiotics are not useful against viral infections, which accounted for 23% of cefdiniruse. When antibiotics are indicated for bacterial URI, agents with better pneumococcal coverage are preferred. Preventing overuse of this costly, broad-spectrum antibiotic is an important focus for antimicrobial stewardship efforts. Background. Acute otitis media (AOM) is a common diagnosis in outpatient pediatrics that often results in antibiotic prescriptions. In 2013, revised clinical practice guidelines for AOM by the American Academy of Pediatrics (AAP) recommended reserving antibiotics and a watchful waiting (WW) approach in most scenarios; amoxicillin ±clavu-lanate as first-line agents if treating; and courses of >7 days to be clearly indicated only in severe cases in those ≤2 years old. Adherence to AOM guidelines amongst pediatric providers, especially in nonacademic outpatient settings, has not been well characterized.
Methods. In a large community-based sepsis point prevalence study, diagnosis, antibiotic prescription, and other data were collected from all patients aged 0 to 18 years seen on September 5, 2016, December 5, 2016, March 6, 2017, and June 5, 2017, in the Emergency Department (ED) of the Women and Children's Hospital of Buffalo, 11 primary pediatric (PMD) offices, and 2 private urgent care centers (UCC) in Buffalo, NY. For this secondary analysis, all children with a provider diagnosis of acute otitis media (AOM) were identified. Adherence to AAP AOM guidelines were analyzed and compared relative to clinical care setting.
Results. Of 2,062 sick visits, 6% (121) were diagnosed with AOM, and in 82% of these antibiotics were prescribed: 91% (39/43) in ED; 70% (21/30) in UCC; 83% (40/48) in PMD, P = 0.071. When prescribed, 69% of antibiotics were first-line agents. In UCC and PMD, oral third-generation cephalosporins were the most common nonfirst-line agents, followed by azithromycin (20% and 8% of all antibiotic prescribed cases respectively). Ninety percent of antibiotic courses were ≥7 days. There were no differences in prescribing practices between outpatient settings Conclusion. A recent study found that WW is clinically appropriate in >50% of pediatric AOM and overall cost-effective. However, in our analysis, antibiotics are still being prescribed in four out of five cases. Non-first-line agents, which are excessively broad and/ or suboptimal in targeting the main pathogens for pediatric AOM, are given in over a quarter of prescriptions. Increasing awareness and adherence to AOM guidelines, in various outpatient settings, should be a major target of pediatric antibiotic stewardship efforts.
Disclosures. Thursday, October 4, 2018: 12:30 PM Background. Pneumonia (PNA) and other respiratory infections are common diagnoses in outpatient pediatrics and often result in antibiotic utilization. Professional society guidelines recommend narrow-spectrum agents, namely amoxicillin/ampicillin, as empiric therapy for the majority of pediatric community-acquired pneumonia. In most respiratory infections other than PNA, antibiotics are not indicated. Adherence to PNA guidelines, and antibiotic use for other respiratory infections, in the varied outpatient settings in which children are seen, has not been well characterized.
Methods. In a large outpatient sepsis point prevalence study, various data were collected from all patients 0 to 18 years of age seen on September 5, 2016 , December 5, 2016 , March 6, 2017 , and June 5, 2017 , in the Emergency Department (ED) of the Women and Children's Hospital of Buffalo, 11 primary pediatric (PMD) offices, and 2 private urgent care centers (UCC) in Buffalo, New York. For this secondary analysis, all children with a provider diagnosis of PNA, bronchitis, bronchiolitis, and upper respiratory infection (URI), were identified. Antibiotic utilization and adherence to Pediatric Infectious Diseases Society PNA (2011) guidelines were analyzed and compared relative to clinical care setting.
